You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

AstraZeneca’s Evusheld not recommended for certain adults

The National Institute for Health and Care Excellence (NICE) has issued draft guidance which fails to recommend AstraZeneca’s tixagevimab-cilgavimab – also known as Evusheld – for the prevention of COVID-19.